¡¡¡¡¡¾²Î¿¼ÎÄÏס¿

¡¡¡¡1 Pennesi G,Caspi, RR, Genetic control of susceptibility in clinical and experimental uveitis. Int Rev Immunol 2002;21(2ª²3):67ª²88

¡¡¡¡2 Martin TM, Kurz DE, Rosenbaum JT, Genetics of uveitis. Ophthalmol Clin North Am 2003;16(4):555ª²565

¡¡¡¡3 Martin TM, Rosenbaum JT, Genetics in uveitis. Int Ophthalmol Clin 2005;45(2):15ª²30

¡¡¡¡4 Sakaguchi M, Sugita S, Sagawa K, Itoh K, Mochizuki M, Cytokine production by T cells infiltrating in the eye of uveitis patients. Jpn J Ophthalmol 1998;42(4):262ª²268

¡¡¡¡5 Karasneh J, Hajeer AH, Barrett J, Ollier WE, Thornhill M, Gul A. Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet¬ðs disease. Rheumatology (Oxford) 2003;42(7):860ª²864

¡¡¡¡6 Alayli G, Aydin F, Coban AY, S¨¹ll¨¹ Y, Cant¨¹rk F, Bek Y, Durupinar B, Cant¨¹rk T.T helper 1 type cytokines polymorphisms: association with susceptibility to Behcet's disease. Clin Rheumatol 2007;26(8):1299ª²1305

¡¡¡¡7 Coskun M, Bacanli A, Sallakci N, Alpsoy E, Yavuzer U, Yegin O. Specific interleukinª²1 gene polymorphisms in Turkish patients with Behcet¬ðs disease. Exp Dermatol 2005;14(2):124ª²129

¡¡¡¡8 Rosenbaum JT, Boney RS, Use of a soluble interleukinª²1 receptor to inhibit ocular inflammation. Curr Eye Res 1991;10(12):1137ª²1139

¡¡¡¡9 Menezo V, Bond SK, Towler HM, Kuo NW, Baharlo B, Wilson AG, Lightman S.Cytokine gene polymorphisms involved in chronicity and complications of anterior uveitis. Cytokine 2006;35(3ª² 4):200ª²206

¡¡¡¡10 Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukinª²18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 2001;12(1):53ª²72

¡¡¡¡11 Musabak U, Pay S, Erdem H, Simsek I, Pekel A, Dinc A, Sengul A. Serum interleukinª²18 levels in patients with Behcet¬ðs disease. Is its expression associated with disease activity or clinical presentaª²tions? Rheumatol Int 2006;26(6):545ª²550

¡¡¡¡12 Giedraitis V, He B, Huang WX, Hillert J.Cloning and mutation analysis of the human ILª²18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 2001;112(1ª²2):146ª²152

¡¡¡¡13 Jang WC, Park SB, Nam YH, Lee SS, Kim JW, Chang IS, Kim KT, Chang HK.Interleukinª²18 gene polymorphisms in Korean patients with Behcet¬ðs disease. Clin Exp Rheumatol 2005;23:S59ª²63

¡¡¡¡14 Lee YJ, Kang SW, Park JJ, Bae YD, Lee EY, Lee EB, Song YW.Interleukinª²18 promoter polymorphisms in patients with Behcet¬ðs disease. Hum Immunol 2006;67(10): 812ª²818

¡¡¡¡15 Santos Lacomba M, Marcos Mart¨ªn C, Gallardo Galera JM, G¨®mez Vidal MA, Collantes Est¨¦vez E, Ram¨ªrez Chamond R, Omar M.Aqueous humor and serum tumor necrosis factorª²alpha in clinical uveitis. Ophthalmic Res 2001;33(5):251ª²255

¡¡¡¡16 Brito BE, O'Rourke LM, Pan Y, Anglin J, Planck SR, Rosenbaum JT. ILª²1 and TNF receptorª²deficient mice show decreased inflammation in an immune complex model of uveitis. Invest Ophthalmol Vis Sci 1999;40(11):2583ª²2589

¡¡¡¡17 Kuo NW, Lympany PA, Menezo V, Lagan AL, John S, Yeo TK, Liyanage S, du Bois RM, Welsh KI, Lightman S. TNFª²857T, a genetic risk marker for acute anterior uveitis. Invest Ophthalmol Vis Sci 2005;46(5):1565ª²1571

¡¡¡¡18 Akman A, Sallakci N, Coskun M, Bacanli A, Yavuzer U, Alpsoy E, Yegin O. TNFª²alpha gene 1031 T/C polymorphism in Turkish patients with Behcet¬ðs disease. Br J Dermatol 2006;155(2):350ª²356

¡¡¡¡19 Magone MT, Whitcup SM. Mechanisms of intraocular inflammaª²tion. Chem Immunol 1999;73:90ª²119

¡¡¡¡20 Zlotnik A, Yoshie O, Chemokines: a new classification system and their role in immunity. Immunity 2000;12(12):121ª²127

¡¡¡¡21 Scapini P,Lapinetª²Vera JA,Gasperini S,Calzetti F,Bazzoni F,Cassatella MA.The neutrophil as a cellular source of chemokines. Immunol Rev2000;177:195ª²203

¡¡¡¡22 Zouboulis CC, Katsantonis J, Ketteler R, Treudler R, Kaklamani E, Hornemann S, Kaklamanis P, Orfanos CE. Adamantiadesª²Behcet¬ðs disease: interleukinª²8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res 2000;292(6):279ª²284

¡¡¡¡23 Saruhanª²Direskeneli G,Yent¨¹r SP,Akmanª²Demir G,Isik N,Serdaroglu P.Cytokines and chemokines in neuroª²Behcet¬ðs disease compared to multiple sclerosis and other neurological diseases. J Neuroimmunol 2003;145(1ª²2):127ª²134

¡¡¡¡24 Verma MJ, Lloyd A, Rager H, Strieter R, Kunkel S, Taub D, Wakefield D. Chemokines in acute anterior uveitis. Curr Eye Res 1997;16(12): 1202ª²1208

¡¡¡¡25 Duymazª²Tozkir J, OilmanV, Uyar FA, Hajeer AH, Saruhanª²Direskeneli G, Gul A. Polymorphisms of the ILª²8 and CXCR2 genes are not associated with Behcet¬ðs disease. J Rheumatol 2005;32:93ª²97

¡¡¡¡26 Yeo TK, Ahad MA, Kuo NW, Spagnolo P, Menezo V, Lympany P, Lightman S. Chemokine gene polymorphisms in idiopathic anterior uveitis. Cytokine 2006;35(1ª²2):29ª²35

¡¡¡¡27 Lee EB, Kim JY, Zhao J, Park MH, Song YW. Haplotype association of ILª²8 gene with Behcet's disease. Tissue Antigens 2007;69(2):128ª²132

¡¡¡¡28 Tuaillon N,Shen DF,Berger RB,Lu B,Rollins BJ,Chan CC.MCPª²1 expression in endotoxinª²induced uveitis. Invest Ophthalmol Vis Sci 2002;43(5):1493ª²1498

¡¡¡¡29 Fang IM, Yang CH, Lin CP, Yang CM, Chen MS. Expression of chemokine and receptors in Lewis rats with experimental autoimmune anterior uveitis. Exp Eye Res 2004;78(6):1043ª²1055

¡¡¡¡30 Rovin BH, Lu L, Saxena R. A novel polymorphism in the MCPª²1 gene regulatory region that influences MCPª²1 expression. Biochem Biophys Res Commun 1999;259(2):344ª²348

¡¡¡¡31 Chen Y, Vaughan RW, Kondeatis E, Fortune F, Graham EM, Stanford MR,Wallace GR. Chemokine gene polymorphisms associate with gender in patients with uveitis. Tissue Antigens 2004;63(1):41ª²45

¡¡¡¡32 Wegscheider BJ, Weger M, Renner W, Posch U, Ulrich S, Hermann J, Ardjomand N, Hallerª²Schober EM, Elª²Shabrawi Y., Role of the CCL2/MCPª²1 ª²2518A>G gene polymorphism in HLAª²B27 associated uveitis. Mol Vis 2005;11:896ª²900

¡¡¡¡33 Ahad MA, Missotten T, Abdallah A, Lympany PA, Lightman S.Polymorphisms of chemokine and chemokine receptor genes in idiopathic immuneª²mediated posterior segment uveitis. Mol Vis 2007;13:388ª²396

¡¡¡¡34 al Sharif F, Ollier WE, Hajeer AH. A rare polymorphism at position ª²28 in the human RANTES promoter. Eur J Immunogenet 1999;26£¨5£©:373ª²374

¡¡¡¡35 Hajeer AH, al Sharif F, Ollier WE. A polymorphism at position ª²403 in the human RANTES promoter. Eur J Immunogenet 1999;26£¨5£©:375ª²376

¡¡¡¡36 Yang X, Ahmad T, Gogus F, Verity D, Wallace GR, Madanat W, Kanawati CA, Stanford MR, Fortune F, Jewell DP, Marshall SE. Analysis of the CC chemokine receptor 5 (CCR5) Delta32 polymorphism in Behcet's disease. Eur J Immunogenet 2004;31£¨1£©:11ª²14

¡¡¡¡37 Mojtahedi Z,Ahmadi SB,Razmkhah M,Azad TK,Rajaee A,Ghaderi A.Association of chemokine receptor 5 (CCR5) delta32 mutation with Behcet¬ðs disease is dependent on gender in Iranian patients. Clin Exp

ÉÏÒ»Ò³  [1] [2]